SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is experiencing significant volatility and a steep selloff following earnings, driven by investor anxiety over slowing U.S. user growth and potential search referral headwinds from AI-driven tools. While the community is deeply divided between long-term bulls highlighting robust revenue growth and record cash flow, and vocal bears pointing to platform moderation issues, AI-generated content, and heavy selling from insiders.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing high community engagement driven by anticipation of upcoming earnings and potential major defense contract announcements that could materially impact its growth. Investors are closely monitoring its role in AI infrastructure and edge computing while navigating volatility, with many highlighting the company's strong fundamentals and institutional positioning as long-term catalysts.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors weigh recent trial setbacks for its cardiovascular drug pipeline against the strong performance of its primary obesity franchise. The community is actively debating the stock's valuation, the long-term potential of the oral Wegovy pill, and the competitive landscape as the firm balances pipeline disappointment with its dominant position in the GLP-1 market.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF (GDX) is a focal point as investors debate whether recent price weakness represents a long-term bottom for the sector or a continuation of bearish trends driven by macroeconomic uncertainty and shifting interest rate expectations. Community discussion is heavily split between those accumulating miners as a hedge against currency debasement and others cautioning that volatility and potential liquidity issues remain elevated.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors digest news of institutional interest from Temasek and potential price target upgrades while closely watching for upcoming quarterly results. The community remains focused on the company's operational growth, potential for margin expansion, and the ongoing debate surrounding its OTC listing status.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently drawing significant community attention as it transitions from a pure EV manufacturer into a broader physical AI and robotics company, highlighted by its advancements in autonomous driving and upcoming mass-production plans for humanoid robots. Investors are actively debating the company's long-term valuation relative to its aggressive technology roadmap, with many closely watching the ramp-up of the Mona L03 and the potential for a fundamental shift in how the market prices its robotics and autonomous driving assets.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is currently trending due to intense market debate over sector rotation, as investors weigh whether to exit overvalued semiconductor and AI infrastructure plays in favor of beaten-down software and cybersecurity names. Community discussions are centered on whether current enterprise software valuations present a durable deep-value opportunity or if AI disruption fears will continue to pressure the sector's long-term growth prospects.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is facing heightened selling pressure as investors grapple with technical downtrends, ongoing commodity volatility, and broader concerns regarding interest rates and geopolitical instability. While the community is actively debating whether these price levels represent a bottoming opportunity or a risk of further capitulation, the prevailing focus remains on the long-term silver supply deficit versus short-term macroeconomic headwinds.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing positive momentum driven by strong quarterly results and a robust growth portfolio, despite ongoing industry concerns regarding patent expirations. Community sentiment remains cautiously optimistic as investors watch for pipeline execution and potential M&A activity within the biopharma sector.

Nintendo Co., Ltd. engages in the development, manufacture, and sale of home entertainment products. Its entertainment products include portable and console game machines and software, trump cards and Karuta (Japanese-style playing cards), multinational consumer electronics, home console hardware such as Nintendo Wii, Nintendo DS, Nintendo 3DS, as well as software for handheld and home console gaming machines. The company was founded by Fusajiro Yamauchi on September 23, 1889 and is headquartered in Kyoto, Japan.

Nintendo Co. Ltd - ADR

Nintendo is trending as investors weigh strong initial Switch 2 sales and robust quarterly revenue against persistent concerns regarding high memory chip costs and potential tariff impacts. Community discussion remains polarized between long-term confidence in the company's IP-driven strategy and frustration over recent downward price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook

Ionis beats Q2 revenues and earnings estimates as commercial growth offsets tough comparisons, while reaffirming its 2026 outlook.

Why Biogen Stock Topped the Market Today

Key PointsIt handily beat analyst estimates on both the top and bottom lines...

Q2 Earnings Season in Full Swing

Biogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised

Biogen tops Q2 earnings and revenue estimates as growth drugs fuel sales, offset MS declines, and support a higher 2026 revenue and EPS outlook.

Investors Await Fed Decision Today

A quarter-points rate hike has been bandied about as a possibility today.

Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Biogen (BIIB) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more

These are the stocks posting the largest moves premarket...

Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates

Biogen (BIIB) delivered earnings and revenue surprises of +18.42% and +9.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?

Biotech earnings take center stage as Viking, Biogen, Bristol Myers, Regeneron and AbbVie prepare to report Q2 2026 results.

The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals

HRMY, ACAD, BIIB, INSM and AGIO are set to report Q2 results, with positive Earnings ESPs suggesting potential earnings surprises.

$BIIB Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.66 down -84.76% YoY
• Reported revenue of $2.74B up 3.42% YoY
• Biogen expects full year 2026 Non-GAAP diluted EPS of $12.00 to $13.00, while total revenue is projected to increase by a mid-single digit percentage compared to 2025 for Biogen.

Stocktwits

Biogen Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.66 down -84.76% YoY
• Reported revenue of $2.74B up 3.42% YoY
• Biogen expects full year 2026 Non-GAAP diluted EPS of $12.00 to $13.00, while total revenue is projected to increase by a mid-single digit percentage compared to 2025 for Biogen.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$BIIB Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.66 down -84.76% YoY
• Reported revenue of $2.74B up 3.42% YoY
• Biogen expects full year 2026 Non-GAAP diluted EPS of $12.00 to $13.00, while total revenue is projected to increase by a mid-single digit percentage compared to 2025 for Biogen.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

BIIB Stock On Track For Worst Day In 2 Years After RBC Questions If Alzheimer’s Drug Benefits Will Replicate In Further Study

Equity

Bearish Sentiment

Track BIIB stock price, charts, news and real-time market activity on Stocktwits. Join the BIIB message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Biogen Inc stock.

BIIB Stock Price Today - Biogen Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BIIBBiogen Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest BIIB News